FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
The agency found no evidence to support the theory that the antimalarial drugs touted by President Trump are effective against the coronavirus.
Mylan
MYL
MYL
$15.88
-$0.31
-1.9%
Price as of July 9, 2020, 4:30 p.m. EDT
View Interactive MYL Charts
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
Interactive Chart
News & Analysis: Mylan
The Fool has written over 200 articles on Mylan.
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Cheaper insulin is on its way.
3 Drug Stocks That Could Soar in 2020
Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally
Mylan will distribute the drug as a COVID-19 treatment in 127 low- and middle-income countries.
What's Behind Mylan's Mixed Q1 Results
The COVID-19 pandemic helped the drugmaker's sales more than it hurt.
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
Regulators take different approaches to the unapproved medications.
3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race
An old malaria drug may unseat newer investigational coronavirus treatments -- if data is confirmed.
Coronavirus Pandemic Puts Upjohn-Mylan Megamerger on Hold
Pfizer's plan to merge its post-exclusivity segment with Mylan will have to wait.
Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?
No, but doctors can still use the drugs despite limited evidence of their effectiveness.
